Home » Topics » Diagnostics, BioWorld Science

Diagnostics, BioWorld Science
RSS

FDA approves Roche CMV test for use in hematopoietic stem cell transplant recipients

May 25, 2016

New studies support utility of GastroPanel to predict stomach cancer risk

May 24, 2016

ETHZ, Roche and Universität Zürich disclose CB2 receptor ligands

May 24, 2016

Beta launch of spinal deformity molecular diagnostic test

May 20, 2016

Biocept launches liquid biopsy test to detect RET oncogene fusions

May 20, 2016

Thermo Fisher Scientific obtains FDA clearance for Elia anti-TG and anti-TPO tests

May 17, 2016

Interim data from Avelas' phase Ib trial of AVB-620 surgical marker

May 11, 2016

LabCorp announces launch of Epi proColon

May 10, 2016

Wyss Institute leads collaborators in development of paper-based diagnostic system for Zika

May 9, 2016

Chembio updates progress in development of point-of-care diagnostic test for Zika virus in Brazil

May 9, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....